With CancerIQ's complete telehealth cancer-risk platform you can virtually screen for cancer predisposition, identify high-risk patients through testing and genetic counseling, and manage their care.
Cancer doesn't stop for COVID-19. Patient safety is vital and early detection is the best way to combat cancer, improve patient outcomes and reduce the cost of care. Converting programs virtually via telehealth is the way forward to keep early detection going strong.
Engage patients with the CancerIQ Screening Toolkit; a short and easy digital questionnaire that can be completed anywhere and allows patient capture of detailed family history and immediately flags patients for counseling, testing and MRI eligibility.
Facilitate comprehensive virtual programs with the CancerIQ Specialist and Manager. Featuring a robust GC workflow with pedigree, order-guidance for appropriate genetic testing, auto-creation of medical necessity forms for payers, and digital patient engagement to drive subsequent visits and treatment adherence.
Patients can complete a short digital questionnaire in the comfort of their own home on their own device.
Utilize the latest NCCN and USPSTF guidelines and Tyrer-Cuzick to identify patients eligible for counseling, testing or MRI.
To not disturb workflow, CancerIQ automatically calculates risk results in digital form so you can communicate patient risk in real-time.
Data entered by the patient from home is immediately available in a clean registry. Staff can easily edit information and update the patient's risk score if appropriate.
Engage and educate patients remotely with robust online pedigree tool.
CASE STUDY: Adventist Health - St. Helena and the AHEAD Program
Volume for the AHEAD Program was down 40% one month into COVID-19. Adventist launched their telehealth program with CancerIQ and are now at over 80% volume in the clinic, with more clinic visits returning and utilizing virtual genetic consults. Fridays are now dedicated 100% to virtual genetic consults and they are averaging an additional 10-15 consults a week (pre-test) that will continue to rise in another month as they consult for post-genetic test results.
The Adventist Health Early All-Around Detection program includes a team of physicians who are specialists in gynecology, internal medicine, urology, oncology/hematology, dermatology and breast and reconstruction surgery who have a shared goal of helping patients in early detection and interventions. This may include increased surveillance and effective treatment plans that will reduce risk of cancer.
Learn more about the AHEAD Program.
High-risk patients need those preventative services and our ability to pick up breast cancer at an early stage. I am so excited to be able to take Hereditary Cancer Risk assessment, genetic counseling and testing to our patients - safely from comforts of their homes!
Candace Westgate, DO, OB-GYN and founder of the AHEAD Program at Adventist Health - St. Helena
Read More about Dr. Westgate's experience here.
515 N. State, Suite 1025
Chicago, IL 60654
Call us: 312-761-3360
info@cancer-iq.com